OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd, a company specializing in pancreatic cancer treatment devices, announced the successful passing of a resolution at their Extraordinary General Meeting, with a significant majority of shareholders’ votes in favor. The detailed voting results were disclosed in compliance with regulatory requirements, reflecting strong support for the company’s proposed actions.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.
